Vinva Investment Management Ltd grew its position in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 10.2% during the third quarter, according to its most recent filing with the SEC. The firm owned 84,704 shares of the company’s stock after acquiring an additional 7,836 shares during the period. Vinva Investment Management Ltd’s holdings in Colgate-Palmolive were worth $8,780,000 at the end of the most recent quarter.
Other large investors have also added to or reduced their stakes in the company. B. Riley Wealth Advisors Inc. increased its position in shares of Colgate-Palmolive by 0.8% during the first quarter. B. Riley Wealth Advisors Inc. now owns 16,639 shares of the company’s stock valued at $1,498,000 after acquiring an additional 138 shares in the last quarter. Hancock Whitney Corp raised its holdings in shares of Colgate-Palmolive by 1.3% during the first quarter. Hancock Whitney Corp now owns 12,017 shares of the company’s stock valued at $1,082,000 after purchasing an additional 151 shares during the last quarter. Citizens Financial Group Inc. RI grew its position in Colgate-Palmolive by 12.4% in the 1st quarter. Citizens Financial Group Inc. RI now owns 14,082 shares of the company’s stock worth $1,268,000 after purchasing an additional 1,549 shares during the period. LRI Investments LLC purchased a new stake in Colgate-Palmolive during the 1st quarter valued at $264,000. Finally, Atria Investments Inc increased its position in Colgate-Palmolive by 3.2% during the first quarter. Atria Investments Inc now owns 67,625 shares of the company’s stock valued at $6,090,000 after acquiring an additional 2,115 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.
Wall Street Analysts Forecast Growth
Several brokerages have recently weighed in on CL. Wells Fargo & Company lowered their price objective on shares of Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating on the stock in a research note on Monday, October 28th. JPMorgan Chase & Co. raised their target price on Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a report on Friday, October 11th. Stifel Nicolaus lowered Colgate-Palmolive from a “buy” rating to a “hold” rating and cut their price target for the company from $105.00 to $101.00 in a report on Monday, October 28th. UBS Group boosted their price objective on Colgate-Palmolive from $119.00 to $122.00 and gave the company a “buy” rating in a research note on Wednesday, September 4th. Finally, Redburn Atlantic upgraded shares of Colgate-Palmolive to a “hold” rating in a research note on Thursday, August 1st. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $105.11.
Insiders Place Their Bets
In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the company’s stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now directly owns 36,726 shares in the company, valued at $3,456,283.86. This represents a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this link. Corporate insiders own 0.37% of the company’s stock.
Colgate-Palmolive Stock Performance
NYSE:CL opened at $96.75 on Thursday. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. The company has a market cap of $79.05 billion, a price-to-earnings ratio of 27.72, a PEG ratio of 3.40 and a beta of 0.42. Colgate-Palmolive has a 1 year low of $75.50 and a 1 year high of $109.30. The stock’s 50 day simple moving average is $97.61 and its two-hundred day simple moving average is $98.58.
Colgate-Palmolive Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.07%. The ex-dividend date was Friday, October 18th. Colgate-Palmolive’s payout ratio is 57.31%.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
See Also
- Five stocks we like better than Colgate-Palmolive
- How to Invest in Insurance Companies: A GuideĀ
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- The 3 Best Blue-Chip Stocks to Buy Now
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.